Skip to content

Low-density lipoprotein cholesterol associated with change in non-culprit plaque lipid burden of acute coronary syndrome

Low-density lipoprotein cholesterol associated with change in non-culprit plaque lipid burden of acute coronary syndrome - Low-density lipoprotein cholesterol associated with change in non-culprit plaque lipid burden of acute coronary syndrome

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000055586
Enrollment
100
Registered
2024-09-30
Start date
2023-12-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute coronary syndrome

Interventions

None listed

Sponsors

Kindai University Faculty of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) patients were admitted with ACS (ST-segment elevation myocardial infarction, non-ST-segment elevation myocardial infarction, and unstable angina pectoris); (2) intermediate stenosis in non-culprit lesions on coronary angiography or CCTA; and (3) NIRS-IVUS evaluation for intermediate stenosis after percutaneous coronary intervention.

Exclusion criteria

Exclusion criteria: (1) chronic kidney disease as shown by an estimated glomerular filtration rate <30 ml/min/1.73 m2; (2) presentation with hemodynamic instability; (3) severe valvular heart diseases, (4) left main trunk lesions; (5) lesions that could not be evaluated by NIRS-IVUS for any reason (e.g., tortuous vessels, severe stenosis, and calcification that made catheter passage difficult); and (6) poor image quality that resulted in an inability to perform CCTA or NIRS-IVUS analysis.

Design outcomes

Primary

MeasureTime frame
In ACS patients who reduced LDL-C to less than 55 mg/dL compared to those who reduced it to between 55 and 70 mg/dL, we will evaluate how the plaques with maxLCBI4mm > 400 and < 400 in non-culprit lesions changed as assessed by NIRS-IVUS. Additionally, we will examine whether there are any changes in lipid markers other than LDL-C in these patients.

Countries

Japan

Contacts

Public ContactKazuyoshi Kakekhi

Kindai University Faculty of Medicine Division of Cardiology

kakehi324@yahoo.co.jp81-72-366-0221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026